Dr Gordon Guyatt, distinguished professor in the department of Health Research Methods, Evidence, and Impact at McMaster University and one of the founders of EBM, discusses reasons behind using aspirin in primary prevention in light of recent studies.
Dr Derek Chu, resident in the Clinical Immunology and Allergy Program at McMaster University and recipient of the 2009 Vanier award from the Canadian Institutes of Health Research (CIHR), discusses implications of the recent IOTA study.
Dr Derek Chu, resident in the Clinical Immunology and Allergy Program at McMaster University and recipient of the 2009 Vanier award from the Canadian Institutes of Health Research (CIHR), discusses implications of the recent IOTA study.
Dr Gordon Guyatt, distinguished professor at McMaster University and one of the founders of EBM, discusses characteristics of a trustworthy guideline.
Dr Gordon Guyatt, distinguished professor in the department of Health Research Methods, Evidence, and Impact at McMaster University and one of the founders of EBM, discusses the role of systematic reviews and meta-analyses in the clinical decision-making process.
Dr Gordon Guyatt, distinguished professor in the department of Health Research Methods, Evidence, and Impact at McMaster University and one of the founders of EBM, draws parallels between EBM and personalized medicine.
Dr Sonia Anand, professor in McMaster University Department of Medicine, discusses implications of the COMPASS trial for the treatment of peripheral vascular disease.
Dr Sonia Anand, inaugural associate chair of equity and diversity of McMaster University's Department of Medicine, talks about gender equity and equality in academic medicine.
Dr Sonia Anand, professor in McMaster University's Department of Medicine, discusses general management of peripheral vascular disease in the context of the COMPASS trial.
Dr Gordon Guyatt, Distinguished Professor at McMaster University's Department of Health Research Methods, Evidence, and Impact and one of the founders of EBM, discusses key messages from the new Canadian guidelines on opioid use in chronic noncancer pain.
English
Polski
Español
українська